1. Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: The Tokyo Women's Medical University model.
- Author
-
Arimura K, Tagaya E, Kikuchi K, Mitsuda T, Yasuda G, Azuma H, Konda N, Ikarashi Y, Chiba Y, Kusama K, Sakama R, Hagiwara S, Shimizu S, Shimamoto K, Nomura M, Yaguchi A, Niinami H, Kondo M, Tanabe K, and Kawana M
- Subjects
- Acute Disease, COVID-19 virology, Female, Healthcare-Associated Pneumonia virology, Hospitals, University, Humans, Middle Aged, SARS-CoV-2 genetics, SARS-CoV-2 isolation & purification, SARS-CoV-2 pathogenicity, Schools, Medical, Severity of Illness Index, Tokyo, COVID-19 diagnosis, COVID-19 prevention & control, COVID-19 Testing methods, Cross Infection diagnosis, Cross Infection prevention & control, Healthcare-Associated Pneumonia diagnosis, Healthcare-Associated Pneumonia prevention & control, Polymerase Chain Reaction methods
- Abstract
Hospital-acquired severe acute respiratory virus coronavirus 2 (SARS-CoV-2) infection is a healthcare challenge. We hypothesized that polymerase chain reaction testing of symptomatic triaged outpatients and all inpatients before hospitalization in Shinjuku, a coronavirus disease 2019 (COVID-19) epicenter in Tokyo, using the Tokyo Women's Medical University (TMWU) model would be feasible and efficient at preventing COVID-19. This retrospective study enrolled 2981 patients from March to May 2020. The prevalence of SARS-CoV-2 infection was 1.81% (95% credible interval [CI]: 0.95-3.47%) in triaged symptomatic outpatients, 0.04% (95% CI: 0.0002-0.2%) in scheduled asymptomatic inpatients, 3.78% (95% CI: 1.82-7.26%) in emergency inpatients, and 2.4% (95% CI: 1.49-3.82%) in symptomatic patients. There were no cases of hospital-acquired SARS-CoV-2 infection. This shows that the TWMU model could prevent hospital-acquired SARS-CoV-2 infection and is feasible and effective in reducing the impact of SARS-CoV-2 infection in the hospitals., Competing Interests: Conflict of Interest The authors have no conflicts of interest., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF